Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ischemic Heart Disease

  Free Subscription


19.10.2026

1 Am Heart J
2 Am J Cardiol
1 Am J Med
2 Angiology
1 Arterioscler Thromb Vasc Biol
1 Atherosclerosis
1 Cardiovasc Res
48 Catheter Cardiovasc Interv
1 Circ Cardiovasc Imaging
2 Circ Cardiovasc Interv
3 Circulation
1 Clin Cardiol
1 Clin Chem
5 Int J Cardiol
3 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 Lancet
1 Mayo Clin Proc
5 N Engl J Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. KOECHLIN L, Lopez-Ayala P, Boeddinghaus J, Sigg N, et al
    A 0/2-Hour Algorithm Using a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay for Suspected Myocardial Infarction.
    Am Heart J. 2026 Oct 13:107625. doi: 10.1016/j.ahj.2026.107625.
    PubMed         Abstract available


    Am J Cardiol

  2. MORTADA I, Lee AW, Buckingham D, Ebel G, et al
    Comparative Cardiovascular Outcomes Associated with Evolocumab Versus Inclisiran Among Patients with Elevated Lipoprotein(a).
    Am J Cardiol. 2026 Oct 13:S0002-9149(26)00631.
    PubMed        

  3. LOVE A, Bui DH, Shahab S, Sanjel A, et al
    A Propensity-Matched Analysis of Pre Versus Concomitant Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Replacement With Frailty-Related High-Risk Features.
    Am J Cardiol. 2026 Oct 10:S0002-9149(26)00630.
    PubMed         Abstract available


    Am J Med

  4. SABOURET P, Giamundo DM, Asher E, De Rosa S, et al
    Pelacarsen and Lp(a)HORIZON: Interpreting the Disconnect Between Lipoprotein(a) Lowering and Cardiovascular Outcomes.
    Am J Med. 2026 Oct 15:S0002-9343(26)00749-7. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available


    Angiology

  5. HASSANEIN A, Rajha HE, Abdel Hamid M, Hashem IE, et al
    Apolipoprotein A (ApoA) in Cardiovascular Disorders: Connections and Insights.
    Angiology. 2026 Oct 12:33197261491118. doi: 10.1177/00033197261491118.
    PubMed         Abstract available

  6. YILDIRIM H, Tonyali M, Tasdemir M
    Early Ulnar Artery Occlusion and Recanalization After Coronary Angiography via Distal Ulnar Access: A Doppler-Followed Case Series.
    Angiology. 2026 Oct 12:33197261491116. doi: 10.1177/00033197261491116.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  7. DIAO K, Lu J, Dimitrakakis A, Liu Z, et al
    AI and Deep Learning in Cardiovascular Imaging: From Risk Stratification to Precision Phenotyping.
    Arterioscler Thromb Vasc Biol. 2026 Oct 15. doi: 10.1161/ATVBAHA.126.324762.
    PubMed         Abstract available


    Atherosclerosis

  8. CHOI BG, Yu H, Rha SW, Ahn J, et al
    Association of beta-blocker therapy with outcomes after ST-segment elevation myocardial infarction stratified by GRACE risk score: A nationwide registry analysis.
    Atherosclerosis. 2026;422:121919.
    PubMed         Abstract available


    Cardiovasc Res

  9. MANANDHAR S, Wu Y, Pathak T, Margulies KB, et al
    Differential cardiac remodelling: patterns of cardiomyocyte morphometry in multiple patient conditions.
    Cardiovasc Res. 2026;122:1964-1977.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  10. MARCHESE A, Squillace M, Demola P, Speziale G, et al
    Buddy Wire-Augmented Intravascular Lithotripsy in Refractory Calcified Coronary Lesions: A Five-Case Series.
    Catheter Cardiovasc Interv. 2026;108:1529-1535.
    PubMed         Abstract available

  11. NUBLA A, Lopez-Arevalo H, Manjunath K, Bajwa B, et al
    Chronic Total Occlusion PCI in Cancer Patients: National Trends and Periprocedural Risk Stratification.
    Catheter Cardiovasc Interv. 2026;108:1536-1541.
    PubMed         Abstract available

  12. KHANDKAR C, Khialani B, Ravindran J, Jain P, et al
    SCORE-CUT: A Randomized Trial Comparison of Scoring, Cutting, and Non-Compliant Balloon Lesion Preparation Strategies for Drug-Coated Balloon Angioplasty-Rationale and Design.
    Catheter Cardiovasc Interv. 2026;108:1558-1563.
    PubMed         Abstract available

  13. HANDE SUB, Sezgin U, Oguzhan A, Esra D, et al
    Acute and Late Angiographic Lumen Assessment of the Coronary Artery Diameter After Drug Coated Balloon Angioplasty.
    Catheter Cardiovasc Interv. 2026 Aug 13. doi: 10.1002/ccd.70805.
    PubMed         Abstract available

  14. MARTINS FILHO E, Gattani R, Fischell TA, Motta RFOS, et al
    Percutaneous Coronary Stentectomy: Redefining Stent Failure Management in the Modern Era.
    Catheter Cardiovasc Interv. 2026 Aug 13. doi: 10.1002/ccd.70815.
    PubMed         Abstract available

  15. YALMAN H, Raimoglu U, Raimoglou D, Durmaz ES, et al
    A Rare Presentation of Behcet's Disease: Coexistence of Intracardiac Thrombi, Coronary Artery Disease, and Pulmonary Thromboembolism.
    Catheter Cardiovasc Interv. 2026;108:1591-1594.
    PubMed         Abstract available

  16. SORAJJA N, Fall KN, Moses JW, Prasad M, et al
    Detection of Post-Stent Medial Dissection and White Thrombus Using Hybrid IVUS OCT Imaging may Help Guide Management.
    Catheter Cardiovasc Interv. 2026 Aug 16. doi: 10.1002/ccd.70821.
    PubMed         Abstract available

  17. O'CALLAGHAN D, Coughlan JJ, Alfonso F, Hahn JY, et al
    Final 2-Year Results of the REFORM Study: A Randomized Trial of Biolimus DCB Versus Paclitaxel DCB for In-Stent Restenosis.
    Catheter Cardiovasc Interv. 2026;108:1609-1616.
    PubMed         Abstract available

  18. THACKRAY SM, Batchelor RJ, Dinh D, Brennan A, et al
    Aorto-Ostial Lesion Percutaneous Coronary Intervention: Clinical Characteristics, Predictors and Clinical Outcomes.
    Catheter Cardiovasc Interv. 2026 Aug 18. doi: 10.1002/ccd.70817.
    PubMed         Abstract available

  19. MARTINS FILHO E, Martins MR, Suruagy Motta RFO, Araujo GN, et al
    Propofol-Based Lubrication to Overcome Equipment Friction in Chronic Total Occlusion PCI: The Propoglide Technique.
    Catheter Cardiovasc Interv. 2026;108:1669-1679.
    PubMed         Abstract available

  20. ISHIO S, Nagasaka T, Taniuchi R, Amanai S, et al
    Clinical Outcomes of Drug-Eluting Stents and Drug-Coated Balloons in Tortuous Small Coronary Lesions.
    Catheter Cardiovasc Interv. 2026;108:1680-1689.
    PubMed         Abstract available

  21. XIAO J, He C, Wang Y, Zhou M, et al
    Spontaneous Coronary Artery Dissection in a Young Women: A Case Report and Literature Review.
    Catheter Cardiovasc Interv. 2026;108:1513-1519.
    PubMed         Abstract available

  22. AYAYO SA, Taxiarchi VP, Jerath A, Kontopantelis E, et al
    Interaction of Operator-Patient Sex on Peri-Procedural Treatments and Major Coronary Outcomes After Percutaneous Coronary Intervention.
    Catheter Cardiovasc Interv. 2026 Aug 5. doi: 10.1002/ccd.70799.
    PubMed         Abstract available

  23. GURBEL PA, Jeong YH, Navarese E, Kubica J, et al
    State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing.
    Catheter Cardiovasc Interv. 2026;108:1482-1495.
    PubMed         Abstract available

  24. ZENG L, Li D
    First-in-Human Use of a Novel Perfusion-Channel Drug-Coated Balloon to Manage Coronary Artery Perforation During Chronic Total Occlusion Intervention: A Case Report.
    Catheter Cardiovasc Interv. 2026;108:1462-1466.
    PubMed         Abstract available

  25. WANG JJ, Liu H, Yao Y, Wu M, et al
    Stent Underexpansion Prediction Is Improved by Intravascular Ultrasound-Based Distance-Averaged Calcium Angles.
    Catheter Cardiovasc Interv. 2026 Aug 4. doi: 10.1002/ccd.70804.
    PubMed         Abstract available

  26. SODOU LA, Temgoua M, Edorh H, Kaziga W, et al
    Does Maximum Troponin T Value Correlate With Acute Coronary Occlusion Among Patients Treated as NSTEMI?
    Catheter Cardiovasc Interv. 2026;108:1467-1472.
    PubMed         Abstract available

  27. NAKAMURA Y, Takagi H
    Balancing Circulatory Support and Ventricular Unloading in Post-Infarction Ventricular Septal Perforation: A Computational Analysis of ECPELLA Support Configurations.
    Catheter Cardiovasc Interv. 2026;108:1428-1434.
    PubMed         Abstract available

  28. HARVEY S, Bashiti H, Helal A, Glean K, et al
    Integrating HEART Score and Early CT Coronary Angiography in a Chest Pain Hot Clinic-A Safe Alternative to Inpatient Care From UK Tertiary Center Experience.
    Catheter Cardiovasc Interv. 2026 Aug 4. doi: 10.1002/ccd.70780.
    PubMed         Abstract available

  29. FU Y, Zhang Z, Li C, Zhang T, et al
    The Combination of the Slipstream and the TD-ADR Techniques: An Effective and Safe Strategy for Precision Recanalization of Complex Chronic Total Occlusions.
    Catheter Cardiovasc Interv. 2026;108:1435-1444.
    PubMed         Abstract available

  30. BATSIKAS S, Apostolos A, Dalby MCD, Panoulas V, et al
    First Report of Kounis Syndrome after Zopiclone-When Morpheus Misfires.
    Catheter Cardiovasc Interv. 2026;108:1452-1456.
    PubMed         Abstract available

  31. MURTHI M, Quevedo A, Saha S, Memdani A, et al
    Hospital-Level Variations in Outcomes and Readmissions Among Patients With STEMI and Cardiogenic Shock Receiving Mechanical Circulatory Support: Insights From a National Cohort.
    Catheter Cardiovasc Interv. 2026;108:1408-1416.
    PubMed         Abstract available

  32. CHEN C, Ni Z, Zhu J, Zang Y, et al
    Comparative Outcomes of Novel Small Balloon Low-Pressure Pullback and Traditional Management for Coronary Intramural Hematoma Complicating PCI.
    Catheter Cardiovasc Interv. 2026;108:1397-1404.
    PubMed         Abstract available

  33. VASSILEV D, Mileva N, Panayotov P, Shurupov V, et al
    Clinical Outcomes After Scoring-Balloon and Sirolimus-Eluting Balloon Strategy in Diffuse Small-Vessel Coronary Artery Disease (SCA-DEB Study): A Single-Center Prospective Study.
    Catheter Cardiovasc Interv. 2026;108:1417-1424.
    PubMed         Abstract available

  34. CHENG Y, Zhou S, Guo J, Cai X, et al
    OCT-Derived Index of Plaque Attenuation as a Quantitative Metric for Histological Plaque Vulnerability in Human Coronary Atherosclerosis.
    Catheter Cardiovasc Interv. 2026;108:1111-1119.
    PubMed         Abstract available

  35. PUGLISI G, Finocchiaro S, Capodanno D
    Physiology-Guided Heart Rate Modulation in Cardiogenic Shock With Myocardial Bridging: Reversing the Inotrope Paradox.
    Catheter Cardiovasc Interv. 2026;108:1120-1123.
    PubMed         Abstract available

  36. KANG DO, Kim S, Her AY, Shin ES, et al
    Drug-Coated Balloon-Based Strategy for De Novo Coronary Artery Disease Across Complex and High-Risk Indicated Percutaneous Coronary Intervention Risk Categories: A Multicenter Registry Study.
    Catheter Cardiovasc Interv. 2026 Jul 16. doi: 10.1002/ccd.70756.
    PubMed         Abstract available

  37. INCESU G, Karadag B, Temiz MK, Incesu IFS, et al
    Patterns of Neoatherosclerotic Plaque Complications in Patients With Stent Failure: An Optical Coherence Tomography Study.
    Catheter Cardiovasc Interv. 2026;108:1157-1164.
    PubMed         Abstract available

  38. NAMNOUM G, Sfeir M
    STEMI in a Patient With Aspirin-Induced Angioedema: A Case for Early Desensitization.
    Catheter Cardiovasc Interv. 2026;108:1165-1168.
    PubMed         Abstract available

  39. ARORA S, Sharma YP, Panda P, Verma S, et al
    Ticagrelor Induced 2:1 Atrio-Ventricular Block After Percutaneous Coronary Intervention to Right Coronary Artery.
    Catheter Cardiovasc Interv. 2026 Jul 19. doi: 10.1002/ccd.70748.
    PubMed         Abstract available

  40. KAUR H, Williford NN, Alexandrou M, Brilakis ES, et al
    FineCross M3 Microcatheter for Balloon Uncrossable Lesions.
    Catheter Cardiovasc Interv. 2026;108:1180-1185.
    PubMed         Abstract available

  41. TARIQ A, Bhatti Z, Khan AH, Laghari M, et al
    Major Adverse Cardiovascular Events in Insulin- Versus Non-Insulin-Treated Type 2 Diabetes Patients Following Percutaneous Coronary Intervention: A Prospective Cohort Study.
    Catheter Cardiovasc Interv. 2026 Jul 21. doi: 10.1002/ccd.70735.
    PubMed         Abstract available

  42. BO-XU D, Zi-Guang S, Ji-Yi Z
    The Sequence of Post-Dilation Matters: Proximal Optimization Technique (POT) Reduces Longitudinal Stent Deformation Assessed by Intravascular Ultrasound.
    Catheter Cardiovasc Interv. 2026 Jul 23. doi: 10.1002/ccd.70774.
    PubMed         Abstract available

  43. GABRIELLI A, Elscot JJ, Camilleri W, Kakar H, et al
    Comparison of Immediate Versus Staged Complete Revascularization in Patients With Index PCI Coronary Complications: A Study on Clinical Outcomes and Predictors of Complications.
    Catheter Cardiovasc Interv. 2026;108:1241-1247.
    PubMed         Abstract available

  44. AKRAWI D, Kadappu K, Xu J, Badie TYN, et al
    VERMONT muQFR: Diagnostic Accuracy of Murray Law-Based 2D-muQFR Compared to 3D-muQFR and vFFR.
    Catheter Cardiovasc Interv. 2026;108:1256-1267.
    PubMed         Abstract available

  45. GASECKA A, Pietrasik A, Pawlowski T, Zimodro JM, et al
    One-Year Outcomes of High-Risk Percutaneous Coronary Interventions With Versus Without Mechanical Circulatory Support: Propensity Score-Matched Analysis.
    Catheter Cardiovasc Interv. 2026 Jul 28. doi: 10.1002/ccd.70749.
    PubMed         Abstract available

  46. NAITO D, Matsuo A, Kasahara T, Ota K, et al
    Calcified Plaque Detachment: Alternative Calcified Plaque Modification After Coronary Intravascular Lithotripsy.
    Catheter Cardiovasc Interv. 2026;108:1279-1286.
    PubMed         Abstract available

  47. SELLA G, Kharsa C, Sammour YM, Bou Chaaya RG, et al
    Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion.
    Catheter Cardiovasc Interv. 2026 Jul 28. doi: 10.1002/ccd.70772.
    PubMed         Abstract available

  48. LLUCH-REQUEREY C, Rosa-Longobardo F, Roa-Garrido J, Menchero AEG, et al
    Stepwise Percutaneous Management of a Giant Coronary Pseudoaneurysm.
    Catheter Cardiovasc Interv. 2026;108:1301-1305.
    PubMed         Abstract available

  49. SETOGUCHI A, Iyama K, Iwasaki R, Kusumoto S, et al
    Evaluation of Treatment Response of Calcified Nodules and Nodular Calcified Lesions Using Mean Density on Coronary Computed Tomography Angiography.
    Catheter Cardiovasc Interv. 2026 Jul 28. doi: 10.1002/ccd.70770.
    PubMed         Abstract available

  50. SPARASCI FM, Cafaro A, Fischetti D, Mandurino-Mirizzi A, et al
    Coronary Perforation During Excimer Laser Angioplasty in a Patient With Prior Thoracic Radiotherapy.
    Catheter Cardiovasc Interv. 2026;108:1337-1343.
    PubMed         Abstract available

  51. SENGUTTUVAN NB, Salahuddin S, Abdulkader RS, Gunasekar S, et al
    Long-Term Cardiovascular Outcomes Following Percutaneous Coronary Intervention of Diffuse Coronary Artery Lesions With Overlapping Homogeneous Versus Heterogeneous Second-Generation Drug-Eluting Stents.
    Catheter Cardiovasc Interv. 2026 Jul 31. doi: 10.1002/ccd.70781.
    PubMed         Abstract available

  52. SELWANOS PPS, Samir A, Bakhoum S, Abdelhamid M, et al
    Neointimal Healing Score After Contemporary Extraplaque Compared to Intraplaque Recanalization of Chronic Total Occlusion: A 6-Month Follow-Up Optical Coherence Tomography Observational Study.
    Catheter Cardiovasc Interv. 2026;108:1762-1772.
    PubMed         Abstract available

  53. GROENLAND FTW, Plantes ACZD, Neleman T, Ligthart JMR, et al
    Primary Percutaneous Coronary Intervention Guided by High-Definition Intravascular Ultrasound (The SPECTRUM Study).
    Catheter Cardiovasc Interv. 2026 Aug 31. doi: 10.1002/ccd.70836.
    PubMed         Abstract available

  54. BASHAR H, Rashid M, Mamas MA, Curzen N, et al
    Use of Intracoronary Pressure Wire Assessment and Association With Outcomes: Insights From the British Cardiovascular Intervention Society National Database.
    Catheter Cardiovasc Interv. 2026;108:1743-1753.
    PubMed         Abstract available

  55. BHATTI KI, Shah JA, Solangi BA, Ali WH, et al
    Post-Dilatation and Risk of Complications in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Cohort Analysis.
    Catheter Cardiovasc Interv. 2026 Aug 26. doi: 10.1002/ccd.70833.
    PubMed         Abstract available

  56. FIROZ A, Akram A, Singh S
    Crossing an Angulated SVG-RCA Anastomosis Using Distal Anchoring and Guide Extension: A Bailout Strategy in STEMI.
    Catheter Cardiovasc Interv. 2026;108:1717-1720.
    PubMed         Abstract available

  57. COCCO M, Sarti A, Verardi FM, Caglioni S, et al
    Evaluating the Impact of Enhanced Stent Visualization on PCI Outcomes in Older Patients With Multivessel Disease.
    Catheter Cardiovasc Interv. 2026;108:1698-1706.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  58. BHATIA HS, Razavi AC, Dardari Z, McClelland RL, et al
    Development and Validation of a Coronary Artery Calcium Volume and Density Score.
    Circ Cardiovasc Imaging. 2026 Oct 12:e020112.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  59. CARRINGTON JG, Nogami K, Kanaji Y, Lewis BR, et al
    Classification and Outcomes of Coronary Microvascular Disease in Myocardial Infarction and Angina With Nonobstructive Coronary Arteries.
    Circ Cardiovasc Interv. 2026 Oct 15:e016552.
    PubMed         Abstract available

  60. FATH AR, Rymer J, Marks A, Wojdyla D, et al
    High-Potency P2Y12 Inhibitors Among Patients With Chronic Coronary Syndrome Undergoing PCI: An Analysis From the NCDR CathPCI Registry.
    Circ Cardiovasc Interv. 2026 Oct 12:e016658.
    PubMed         Abstract available


    Circulation

  61. BEAVERS CJ, Dobesh PP, Cushman M, DiDomenico RJ, et al
    Multidisciplinary Approach to Antiplatelet Management in Coronary Syndromes: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Oct 13. doi: 10.1161/CIR.0000000000001478.
    PubMed         Abstract available

  62. PARK S, Gupta DK, Izzy M, VanWagner LB, et al
    Cardiovascular Complications of Chronic Liver Disease.
    Circulation. 2026;154:1518-1536.
    PubMed         Abstract available

  63. LYON S, de Ferranti SD, Moran AE, Zhang Y, et al
    Trends and Distribution of Low-Density Lipoprotein Cholesterol Levels Among US Adults and Adolescents Without Atherosclerotic Cardiovascular Disease, 1999 to 2023.
    Circulation. 2026;154:1510-1514.
    PubMed        


    Clin Cardiol

  64. DAYER N, Auberson D, Lu H, Costa E, et al
    H(2)FPEF Score and Charlson Comorbidity Index as Independent Predictors of Cardiovascular Outcomes in Elderly Patients Undergoing Geriatric Rehabilitation.
    Clin Cardiol. 2026;49:e70496.
    PubMed         Abstract available


    Clin Chem

  65. IVANOVA AA, Schieltz DM, Gardner MS, Parks BA, et al
    Association between Glycoprotein Acetylation-Indicated Inflammation and Small HDL Particle Number in Coronary Artery Disease.
    Clin Chem. 2026 Oct 15:hvag129. doi: 10.1093.
    PubMed         Abstract available


    Int J Cardiol

  66. SERIKAWA N, Yoshikawa M, Arashi H, Shibahashi E, et al
    Estimated cumulative LDL-C exposure and risk of recurrent cardiovascular events after acute coronary syndrome.
    Int J Cardiol. 2026 Sep 15:134781. doi: 10.1016/j.ijcard.2026.134781.
    PubMed         Abstract available

  67. GARNICA DE, Bautista-Mier H, Isaac R, Nudelman J, et al
    All-cause mortality and appropriate implantable cardioverter-defibrillator shocks with first-line catheter ablation versus antiarrhythmic drugs in ischemic ventricular tachycardia: A systematic review and Meta-analysis of randomized controlled trials.
    Int J Cardiol. 2026;464:134775.
    PubMed         Abstract available

  68. GABRIELLI FA, Bencardino G, Ballacci F, Del Greco A, et al
    Speckle tracking echocardiography predicts electroanatomical scar in patients with ischaemic cardiomyopathy undergoing catheter ablation for ventricular tachycardia.
    Int J Cardiol. 2026;464:134774.
    PubMed         Abstract available

  69. ZENG X, Nie Y, Zhang Z, Quan Y, et al
    Diagnostic performance of sASGR1, Cathepsin V, and the systemic immune-inflammation index for coronary vulnerable plaques: A virtual histology-intravascular ultrasound analysis.
    Int J Cardiol. 2026;464:134762.
    PubMed         Abstract available

  70. ERICHSEN PA, Afzal M, Byrne C, Frary JMC, et al
    Serial high-sensitivity troponin-T and risk of heart failure in individuals with suspected acute coronary syndrome.
    Int J Cardiol. 2026;464:134748.
    PubMed         Abstract available


    J Am Coll Cardiol

  71. MYERS J, Beckie TM, Chastin S, Fleg JL, et al
    Exercise Prescriptions for Cardiovascular Health in Adults: 2026 ACC Scientific Statement: A Report of the American College of Cardiology.
    J Am Coll Cardiol. 2026 Oct 15:S0735-1097(26)07722.
    PubMed         Abstract available

  72. ZHAO Z, Li M, Wang Z, Jiang T, et al
    Occupational Disparities in Cardiovascular Risk and Management in Contemporary China.
    J Am Coll Cardiol. 2026 Oct 1:S0735-1097(26)07764.
    PubMed         Abstract available

  73. YONG CM, Al-Lamee R, Spatz ES
    When Universal Is Not Uniform: Sex and the Definition of Myocardial Infarction.
    J Am Coll Cardiol. 2026 Oct 3:S0735-1097(26)07840.
    PubMed        


    J Cardiovasc Pharmacol

  74. EL DARZI A, El Darzi R, Kanbar K, Iratni R, et al
    Targeting Vascular Smooth Muscle Cell Senescence for Cardiovascular Pharmacology: Mechanisms and Therapeutic Perspectives.
    J Cardiovasc Pharmacol. 2026 Oct 16. doi: 10.1097/FJC.0000000000001891.
    PubMed         Abstract available


    Lancet

  75. KANG YM, Nauck MA
    Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes.
    Lancet. 2026;408:1526-1527.
    PubMed        


    Mayo Clin Proc

  76. WEIGHT N, Butler T, Rashid M, Cole A, et al
    The Burden of Type 1 Peri-Operative Myocardial Infarction After Non-Cardiac Surgery: Insights From the Myocardial Ischaemia National Audit Project From 2010-2023.
    Mayo Clin Proc. 2026 Oct 15:S0025-6196(26)18801.
    PubMed         Abstract available


    N Engl J Med

  77. TIAN J, Stone GW, Yu B
    Extended DAPT for Multivessel Coronary Artery Disease. Reply.
    N Engl J Med. 2026;395:1561.
    PubMed        

  78. NARULA S, Nanna MG
    Extended DAPT for Multivessel Coronary Artery Disease.
    N Engl J Med. 2026;395:1560-1561.
    PubMed        

  79. YEH RW, Secemsky EA, Cohen DJ
    Extended DAPT for Multivessel Coronary Artery Disease.
    N Engl J Med. 2026;395:1559-1560.
    PubMed        

  80. CASTIELLO DS, Spitzer E
    Extended DAPT for Multivessel Coronary Artery Disease.
    N Engl J Med. 2026;395:1559.
    PubMed        

  81. RUSSO M, Vergallo R, Jang IK
    Extended DAPT for Multivessel Coronary Artery Disease.
    N Engl J Med. 2026;395:1558-1559.
    PubMed        


    PLoS One

  82. GOZDOWSKA R, Konopka M, Hojka-Osinska A, Jas G, et al
    Circulating microRNAs as potential candidate biomarkers of left ventricular reverse remodeling after myocardial infarction: A pilot study.
    PLoS One. 2026;21:e0360414.
    PubMed         Abstract available

  83. LANGE SA, Engelbertz C, Makowski L, Droge P, et al
    Differences in treatment and outcome of patients with ST- elevation myocardial infarction (STEMI) and non-STEMI in Germany.
    PLoS One. 2026;21:e0343889.
    PubMed         Abstract available

  84. CHEN H, Li Y, Liu M, Chi Y, et al
    Protection of beta-blocker and 5-hydroxytryptamine 1A receptor agonist on myocardial ischemia injury in rats by regulating the NLRP3/Caspase-1/GSDMD pathway.
    PLoS One. 2026;21:e0360695.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum